These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4083567)

  • 21. Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.
    Sharpe DN; Coxon R
    Eur J Clin Pharmacol; 1983; 25(4):539-45. PubMed ID: 6653650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF; Ireland MA; Littler WA
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure.
    Fitzpatrick D; Ikram H; Nicholls MG; Espiner EA
    Circulation; 1983 Mar; 67(3):613-9. PubMed ID: 6821903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
    Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
    Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
    J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The haemodynamic effects of dopamine and prenalterol in patients after cardiac valve surgery.
    Tydén H; Johansson L; Nyström SO
    Acta Anaesthesiol Scand; 1982 Oct; 26(5):468-73. PubMed ID: 6128857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous prenalterol in acute and chronic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
    Coulombe D
    Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
    Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prenalterol administered orally in patients with congestive heart failure.
    Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
    Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenalterol in cardiogenic shock following acute myocardial infarction.
    Coma-Canella I; Lopez-Sendon J; Jadraque LM
    Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
    Amende I; Simon R; Hood WP; Lichtlen PR
    Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
    Oltmanns D; Wester HA; Stein R
    Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.